Mon, Apr 21, 2014, 4:08 AM EDT - U.S. Markets open in 5 hrs 22 mins


% | $
Quotes you view appear here for quick access.

StemCells Inc. Message Board

  • hwmccusker hwmccusker May 10, 2013 6:06 AM Flag

    Q1/13 Results – BUY

    A good conference call – the net loss dropped $3.8 million and the share loss dropped $0.28 with great progress on many ongoing projects.Beating or missing analysts expectations is irrelevant at this point. STEM is on track, and focused on accelerating enrollment in ongoing trials. The most recent data from the spinal cord injury trial showed gains in sensory function observed at the 6 month time point in 2 of 3 patients had persisted through the 12 month assessment, and that 1 of the 2 had converted from a complete injury to an incomplete injury classification. But, STEM has to be more focused on cash burn and expenditures – having reached agreement with the CIRM for $19.3 million in funding in the form of a … forgivable loan and with Silicon Valley Bank for a $10 million loan – still debt.

    Let’s not forget – STEM entered into the …agreement with CIRM for $19.3 million to help fund … pre-clinical development and IND-enabling activities … of its HuCNS-SC cells for Alzheimer’s disease, with the goal of filing an IND application within … 4 years . The funding, which is in the form of a forgivable loan, was awarded under CIRM’s Disease Team Therapy Development Award program (RFA 10-05). STEM declined a 2nd award under RFA 10-05 for cervical spinal cord injury.The order book for April was strong, however, getting STEM off to a positive start for Q2/13. One over-riding question – is there a succession planning process in place – love Marty but even I an – old.

    STEM closed at $1.90 on 4/9 up a penny from for 4/8/13. A BUY on the CIRM funding, anticipated IND filing and clinical data.

    Sentiment: Buy

1.25+0.02(+1.63%)Apr 17 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
AstraZeneca PLC
NYSEThu, Apr 17, 2014 4:00 PM EDT
Urban Outfitters Inc.
NasdaqGSThu, Apr 17, 2014 4:00 PM EDT